Top banner
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo

SCIENCE IN THE NEWS DAILY

Vaccine Doubles Brain Cancer Survival Time

from the Guardian (UK)

A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.

Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.

Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."

Read more ...


comments powered by Disqus
 

EMAIL TO A FRIEND :


Bottom Banner